OncoTargets and Therapy
Volume 10, 2017 - Issue
Open access
52
Views
3
CrossRef citations to date
0
Altmetric
Original Research
VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma
Kalyan Nadiminti1 Division of Hematology/Oncology;2 Holden Comprehensive Cancer Center
, Kamal Kant Singh Abbi2 Holden Comprehensive Cancer Center;3 Department of Internal Medicine, Blood and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA, USA
, Sarah L Mott2 Holden Comprehensive Cancer Center
, Lindsay Dozeman2 Holden Comprehensive Cancer Center
, Annick Tricot2 Holden Comprehensive Cancer Center
, Allyson Schultz2 Holden Comprehensive Cancer Center
, Sonya Behrends2 Holden Comprehensive Cancer Center;3 Department of Internal Medicine, Blood and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA, USA
, Fenghuang Zhan2 Holden Comprehensive Cancer Center;3 Department of Internal Medicine, Blood and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA, USA
& Guido Tricot2 Holden Comprehensive Cancer Center;3 Department of Internal Medicine, Blood and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA, USACorrespondence[email protected]
show all
Pages 217-226
|
Published online: 06 Jan 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.